Open access
Aug 2026
In silico Investigation of Marine Natural Products Targeting Dual PD-L1 and VISTA as Potential Cancer Immunotherapy Agents
The identification of marine-derived compounds addresses the need to overcome resistance to single-checkpoint immunotherapy and are regarded as earlystage lead scaffolds requiring structural optimization rather than hits with acceptable overall safety profiles.
Jeevan Patra, Surya Nath Pandey, Harishchandra Verma et al.
· Current Chemical Biology · 0 citations